Awards & Advancement

Recent Industry Personnel News

Tuesday, May 29, 2007

  • MDS Pharma Services, a contract research organization (CRO) based in King of Prussia, Pa. has named James Pusey as the company’s vice president and general manager of its global clinical development business. The group manages MDS’ late stage trials. Prior to MDS, Pusey was chief executive officer at the biotech company OrthoLogic. He also served as executive vice president for neurology at Serono and a vice president of marketing at AstraZeneca’s CNS, Pain and Infection group.

[Read More]

John Cline Resigns from etrials

Monday, May 21, 2007

Morrisville, N.C.-based eClinical company etrials reported that John Cline, founder and long time chief executive officer of the company, has resigned his post effective immediately in order to pursue other “entrepreneurial endeavors.” He will, however, remain a member of the board of directors.

[Read More]

Recent Industry Personnel Changes

Monday, April 30, 2007

  • Cambridge, Mass.-based CRO PROMETRIKA has hired Gretchen Richards to the role of director of clinical operations. In her new role, Richards will oversee the company’s new clinical management services group. The group will offer study assessment and planning, site selection, trial and regulatory management, and monitoring. Prior to joining the company, Richards served as director of clinical research at NUCRYST Pharmaceuticals and has held various roles at Parexel International, MacroChem, Hydridon, and Millennium Pharmaceuticals.

[Read More]

Recent Industry Personnel Changes

Monday, April 16, 2007

  • New York-based eClinical firm Medidata Solutionshas appointed Hugh Levaux to the position of vice president of product strategy. Levaux is the former chief executive officer of Ninaza, an electronic data capture company formerly based in San Mateo, Calif. Ninaza was acquired just this month by Octagon Research Solutions. Prior to Ninaza, Levaux held various positions at Quintiles, CareScience, and the RAND Corp. Levaux also worked as vice presient of Operations at the Lewin Group, a division of Quintiles, where he managed consulting projects on health economics, quality of life, and reimbursement.

[Read More]

Recent Industry Personnel Changes

Monday, March 26, 2007

  • Premier Research Group, a Philadelphia-based contract research organization (CRO), appointed Troy McCall, Ph.D., as the company’s new chief operating officer. He will be responsible for Premier’s global clinical trial operations. McCall is returning to the company after leaving Premier as vice president of business development to become president and chief executive officer of eClinical firm, Advanced Clinical Research Services (ACRS).

[Read More]

Recent Industry Personnel Changes

Tuesday, March 13, 2007

  • The Association of Clinical Research Organizations (ACRO) has elected new officers to its board. ACRO elected PharmaNet Development Group’s chief executive officer Jeffery McMullen to head the group as its chairman. David Spaight, president of MDS Pharma Services will assist in that role as chair-elect. McMullen replaces Candace Kendle, co-founder and chief executive officer of Kendle International.

[Read More]

Anapharm Under New Leadership

Friday, February 23, 2007

Princeton, N.J.-based PharmaNet Development Group is showing more signs of positive change as it attempts to move forward after troubled times. It announced this week that it appointed Johane Boucher-Champagne president and chief executive of its Anapharm unit, a phase I and bioequivalencey business based in Quebec City, Canada.

[Read More]

Progress On Clinical Results Transparency

Friday, February 2, 2007

Since the International Committee of Medical Journal Editors (ICMJE) announced in September 2004 that it would consider for publication an article about a research project only if it was posted to a central registry before September 13, 2005, pharmaceutical companies have committed significant personnel, time and money to the issue of clinical trials transparency. And their efforts are paying off.

[Read More]

Covance Rings Closing Bell at NYSE

Friday, January 12, 2007

Chairman and chief executive officer Joe Herring of the Princeton, New Jersey-based CRO Covance ran the closing bell at the New York Stock Exchange (NYSE) on Thursday. The event was to honor Covance’s tenth year as a publicly traded company. On the company 1st day of opening trading in 1997, Covance’s stock was worth $19.25 per share. Ten years later, the stock is worth more than $60 per share; closing Friday at $63.36.

[Read More]

Patrick Donnelly Resigns From PRA

Tuesday, December 26, 2006

PRA International announced the resignation of the company’s president and chief executive officer, Patrick Donnelly. He will work as a consultant for 18 months and will receive $2,000 for each day as a consultant. PRA went public, acquired 10 companies and increased its global operations during the past 13 years under Donnelly as CEO.

[Read More]